Beyond these considerations, it must be highlighted that the ETV6/NTRK3 is the most frequent structural rearrangement involving NTRK genes described in thyroid cancer [2,3,12,23]; therefore, a screening based on IHC testing could miss essential information in thyroid tumors. This evidence concerns the gene NTRK3 and thyroid gland carcinoma.